Terms: = Germ cell tumor AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45
409 results:
1. Review of Patient Gene Profiles Obtained through a Non-Negative Matrix Factorization-Based Framework to Determine the Role Inflammation Plays in Neuroblastoma Pathogenesis.
Boccarelli A; Del Buono N; Esposito F
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673990
[TBL] [Abstract] [Full Text] [Related]
2. Predicting immunotherapy response in melanoma using a novel tumor immunological phenotype-related gene index.
Zheng S; He A; Chen C; Gu J; Wei C; Chen Z; Liu J
Front Immunol; 2024; 15():1343425. PubMed ID: 38571962
[TBL] [Abstract] [Full Text] [Related]
3. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
Su DG; Schoenfeld DA; Ibrahim W; Cabrejo R; Djureinovic D; Baumann R; Rimm DL; Khan SA; Halaban R; Kluger HM; Olino K; Galan A; Clune J
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519058
[TBL] [Abstract] [Full Text] [Related]
4. Identifying tumor Microenvironment Biomarkers in Adherent and Cystic Vestibular Schwannomas.
Zhang L; Kuo HC; Duhon BH; Adunka OF; Dodson EE; Hardesty DA; Prevedello DM; Otero JJ; Ren Y
Otol Neurotol; 2024 Feb; 45(2):e113-e122. PubMed ID: 38082472
[TBL] [Abstract] [Full Text] [Related]
5. Anterior mediastinal neuroblastoma in an adult: an additional case of a rare tumor in an unusual location with review of the literature.
Collins K; Ulbright TM; Davis JL
Diagn Pathol; 2023 Nov; 18(1):127. PubMed ID: 38031161
[TBL] [Abstract] [Full Text] [Related]
6. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
7. ptprc functions as a prognosis biomarker in the tumor microenvironment of cutaneous melanoma.
Li X; Yue Z; Wang D; Zhou L
Sci Rep; 2023 Nov; 13(1):20617. PubMed ID: 37996489
[TBL] [Abstract] [Full Text] [Related]
8. Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy.
Martinez-Morilla S; Moutafi M; Fernandez AI; Jessel S; Divakar P; Wong PF; Garcia-Milian R; Schalper KA; Kluger HM; Rimm DL
Oncoimmunology; 2023; 12(1):2260618. PubMed ID: 37781235
[TBL] [Abstract] [Full Text] [Related]
9. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
10. Generalized Reddish Skin Nodules.
Hamijoyo L; Yaddin DF; Wijaya I; Fianza PI; Usman HA; Hernowo BS; Ceana HY; Pangastuti M; Hartantri Y
Acta Med Indones; 2023 Apr; 55(2):223-225. PubMed ID: 37524604
[TBL] [Abstract] [Full Text] [Related]
11. Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma cells: Biological and Clinical Relevance.
Rapanotti MC; Cugini E; Campione E; Di Raimondo C; Costanza G; Rossi P; Ferlosio A; Bernardini S; Orlandi A; De Luca A; Bianchi L
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511550
[TBL] [Abstract] [Full Text] [Related]
12. CD71
Bozorgmehr N; Okoye I; Mashhouri S; Lu J; Koleva P; Walker J; Elahi S
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37236637
[TBL] [Abstract] [Full Text] [Related]
13. Small Gene Networks Delineate Immune cell States and Characterize Immunotherapy Response in Melanoma.
Egan D; Kreileder M; Nabhan M; Iglesias-Martinez LF; Dovedi SJ; Valge-Archer V; Grover A; Wilkinson RW; Slidel T; Bendtsen C; Barrett IP; Brennan DJ; Kolch W; Zhernovkov V
Cancer Immunol Res; 2023 Aug; 11(8):1125-1136. PubMed ID: 37229623
[TBL] [Abstract] [Full Text] [Related]
14. Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencing.
de Koning W; Feenstra FF; Calkoen FGJ; van der Lugt J; Kester LA; Mustafa DAM
Cancer Immunol Immunother; 2023 Aug; 72(8):2659-2670. PubMed ID: 37072536
[TBL] [Abstract] [Full Text] [Related]
15. Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
Goddard J; Castle J; Southworth E; Fletcher A; Crosier S; Martin-Guerrero I; García-Ariza M; Navajas A; Masliah-Planchon J; Bourdeaut F; Dufour C; Ayrault O; Goschzik T; Pietsch T; Sill M; Pfister SM; Rutkowski S; Richardson S; Hill RM; Williamson D; Bailey S; Schwalbe EC; Clifford SC; Hicks D
Acta Neuropathol; 2023 May; 145(5):651-666. PubMed ID: 37014508
[TBL] [Abstract] [Full Text] [Related]
16. Littoral cell angioma discovered after splenectomy in a patient with non-Hodgkin lymphoma and melanoma. Case report and review.
Schotte H; Pascotto B; Rosso E; S Azagra J; De Blasi V
Ann Ital Chir; 2023 Mar; 12():. PubMed ID: 36994478
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of microRNA-125a expression status in molecular groups of pediatric medulloblastoma.
Hamam SM; Abdelzaher E; Fadel SH; Nassra RA; Sharafeldin HA
Childs Nerv Syst; 2023 Jul; 39(7):1869-1880. PubMed ID: 36892621
[TBL] [Abstract] [Full Text] [Related]
18. Oligodendroglioma metastasizing to cervical lymph node: Rare entity diagnosed on fine-needle aspiration cytology.
Kataria SP; Mahak ; Kumar S; Singh G; Singh S
Diagn Cytopathol; 2023 Apr; 51(4):E124-E128. PubMed ID: 36628997
[TBL] [Abstract] [Full Text] [Related]
19. Clinicomorphological and molecular analysis of medulloblastoma and association with survival: A single tertiary care center experience.
Badiger S; Gudipati A; Uppin M; Konatam ML; Yeramneni VK; Bhattacharjee S; Saradhi MV; Patnaik S; Irukulla M
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S592-S602. PubMed ID: 38384024
[TBL] [Abstract] [Full Text] [Related]
20. Single-cell next-generation sequencing of circulating tumor cells in patients with neuroblastoma.
Kojima M; Harada T; Fukazawa T; Kurihara S; Touge R; Saeki I; Takahashi S; Hiyama E
Cancer Sci; 2023 Apr; 114(4):1616-1624. PubMed ID: 36571449
[TBL] [Abstract] [Full Text] [Related]
[Next]
